BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20207784)

  • 1. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
    Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
    Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
    Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV; Link J; Byrnes JK; Dyment DA; Giovannoni G; Hintzen RQ; Sundqvist E; Kockum I; Smestad C; Lie BA; Harbo HF; Padyukov L; Alfredsson L; Olsson T; Sadovnick AD; Hillert J; Ebers GC
    Neurology; 2009 Dec; 73(24):2107-11. PubMed ID: 20018638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.
    Rojana-udomsart A; James I; Castley A; Needham M; Scott A; Day T; Kiers L; Corbett A; Sue C; Witt C; Martinez P; Christiansen F; Mastaglia F
    J Neuroimmunol; 2012 Sep; 250(1-2):77-82. PubMed ID: 22633068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
    Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
    Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
    Qiu W; Wu JS; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Clin Neurosci; 2010 Aug; 17(8):1009-13. PubMed ID: 20580995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
    Wu JS; James I; Qiu W; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neuroimmunol; 2010 Feb; 219(1-2):109-13. PubMed ID: 20006387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
    Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
    Aláez C; Corona T; Ruano L; Flores H; Loyola M; Gorodezky C
    Acta Neurol Scand; 2005 Nov; 112(5):317-22. PubMed ID: 16218914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.